LXRX

MKT CAP:$919M

Lexicon Pharmaceuticals Inc

Market Cap

$919M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.91+$0.77 (+67.54%)

Jun 5, 2026

52W High $2.4452W Low $0.67

Company Details

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered ...

CEO

—

IPO Date

Apr 7, 2000

Website

www.lexpharma.com

Key Metrics TTM

Revenue

$70M

+123.1% YoY

Net Income

-$26M

EPS (Diluted)

Free Cash Flow

-$39M

Revenue / Share

$0.17

Gross Margin

99.1%

Operating Margin

-34.8%

Net Margin

-37.5%

FCF Margin

-55.7%

P/S

13.2x

P/E

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

May 7, 2026

$21M+1572.1%

FY 2025

Mar 5, 2026

$50M+60.2%

Q4 2025

Mar 5, 2026

$5M-79.3%

Q3 2025

Nov 6, 2025

$14M+710.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee